Insights On Upstream Manufacturing
-
Metabolic Rate Monitoring Of Undifferentiated iPS Cells And Expression Analysis Of Differentiation Markers
9/22/2026
Continuous tracking of glucose and lactate kinetics provides clear quantitative indicators of stem cell pluripotency and early differentiation to optimize culture timing.
-
Visualizing The Metabolic Profile Of Immune Cells With Metabolic Inhibitors
9/22/2026
Continuous in-line measurement tracks real-time shifts in cellular energy pathways under metabolic inhibition, delivering precise insights into immune cell function and dynamics.
-
Improving Scale-Up Starts With Expression Strategy
9/21/2026
Early expression screening and strain-engineering strategies can reveal manufacturing risks and clarify which recombinant protein candidates are worth advancing before major investments are made.
-
How Does GS piggyBac® Transposon Technology Work?
9/18/2026
Targeted genomic integration offers a more deliberate path to stable, high-expressing CHO cell lines than random integration methods have traditionally allowed.
-
How Can The GS Effex® Cell Line Increase The Potency Of Therapeutic Antibodies?
9/18/2026
Learn how GS Effex® integrates into our GS Gene Expression System®, letting customers use the same expression vectors, GS piggyBac® transposase technology, and media while incorporating the cell line into existing workflows.
-
What Is The GS Discovery® Transient Expression System?
9/18/2026
Two transient expression approaches, one optimized for speed and one for higher titers, are examined alongside the consistency advantages of a shared host cell and vector system.
-
How Do I Choose An Expression System For My Biotherapeutic Molecule?
9/18/2026
Selecting an expression system early in biotherapeutic development depends on molecular complexity, glycosylation requirements, and other structural characteristics that differ across platforms.
-
Inside The Technology Advancing CHO Therapeutic Protein Expression
9/18/2026
Watch as Dr. Peter O'Callaghan, Senior Director and Head of Expression System Sciences, Licensing, answers key questions about the GS Gene Expression System® and the technologies behind its performance.
-
How Semi-Targeted Integration Changes The Biologics Game
9/17/2026
Modern biologics development requires precise cell line engineering. Semi-targeted integration enables stable, high-producing cell pools faster, accelerating development timelines.
-
Characterizing Gene-Edited T Cells Using High-Throughput Expression
9/16/2026
Gene expression profiling reveals whether engineered T cells display intended molecular changes while helping identify unwanted effects. See how a standardized workflow can improve consistency.